Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Alvaro Macieira-Coelho

Alvaro Macieira-Coelho

French National Institute of Health France

Liane Deligdisch

Liane Deligdisch

Mount Sinai School of Medicine USA

Alain Charest

Alain Charest

Harvard Medical School USA

Jack C. Westman

Jack C. Westman

University of Wisconsin School of Medicine and Public Health USA

Sabine Mai

Sabine Mai

University of Manitoba Canada

Nichola C Garbett

Nichola C Garbett

University of Louisville School of Medicine USA

Bo Yuan

Bo Yuan

Tokyo University of Pharmacy and Life Sciences Japan

Katharina Pachmann

Katharina Pachmann

SIMFO GmbH Germany

Cancer Science 2017

About Conference

ConferenceSeries Ltd extends its heartfelt welcome to “19th Euro Congress on Cancer Science and Therapy  that will be held in Lisbon, Portugal during July 17-19, 2017.The conference will be organised around the theme ‘Defining an Evolved Approach towards Cancer Treatment’

Cancer Science 2017 will provide an unparalleled prospect to get associated with leading oncologists, doctors, scientists, academicians, specialists & business associates coming from all over the world. As the theme of the conference relates it serves as a global platform to converse concerning the current developments, recent advances, new approaches and future approaches in the field of cancer science & therapy.     

Cancer Science & Therapy Congress 2017 conference will be organized by ConferenceSeries Ltd  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse fields of Medical, Pharmaceutical, Clinical, Engineering, Science , Technology and Business .Cancer Science & Therapy deals with study of basic researches in the field of cancer & oncology. It involves identifying causes and to develop strategies for diagnosis, prevention, treatment and cure for this dreadful disease.

Why to attend Cancer Science 2017?

Cancer Science 2017 is the primary event that brings together a unique and international experts, researchers and decision makers both from academia and industry across the world to exchange their knowledge, expertise and research innovations in the arena of cancer treatment. During the passage of the three day conference, you can avail opportunity to both network and perceive leaders from the global academic and corporate cancer research communities.

The main emphasis will be on aspects such as Cancer Cell Biology, Tumour & Cancer Immunology, Organ Specific Cancers, Cancer Genetics, Anti- Cancer Therapies, Cancer Biomarkers, Cancer Immunobiology, Radiation Oncology, Surgical Oncology, Oncology Nursing, Cancer Diagnosis, Stem Cell Therapy,  Cancer Management & Prevention,Alternative Cancer Treatment etc.

Target Audience

  • Academicians
  • Oncologists
  • Pathologists
  • Cancer & Oncology Societies Professionals
  • Bio-Medical Company professionals
  • Corporate Cancer Research Professional
  • Research Scholars
  • Pharmacists
  • Business Entrepreneurs
  • Software Developing Companies
  • Medical Devices Companies
  • Biotechnology Companies

Sessions/Tracks

Cancer Science 2017 is an international conference on the topics of the future direction of the Cancer Treatment. As the theme of the conference emphasises ‘Defining an Evolved Approach towards Cancer Treatment’, the Conference is an outstanding international forum to present and discuss progress in exploration, expansion, ideals, and applications of the topics related to the Cancer Science & Therapy.

In addition to the multidisciplinary talks, Keynote sessions, and lectures relevant to cancer science & therapy, the Cancer Science 2017 is a complete 3 day event with panel discussions, open Q & A to generate a prime learning knowledge between participants.

Scientific Session of the Conference includes:

Cancer Cell Biology

Cancer cells are typically defied by their capacity to divide uncontrollably. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues. In addition, as these tumors grow, some cancer cells can break off and travel to distant places in the body through the blood or the lymph system and form new tumors far from the original tumor. Cancer cells arise from the body’s own tissues. Cancer Cell Biology includes the molecular, biochemical, and cell-based approaches to better understand cancer pathogenesis.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Organ-Defined Cancers

Cancer has a diversified nature in relation to the organ specificity. Cancer is a group of more than 100 diseases that develop across time in virtually any of the body’s tissues. Each type of cancer has its unique features; the basic processes that produce cancer are quite similar in all forms of the disease. Organ Specific Cancers are cancers named basing on the location of cancer in the body organ. The various types of cancers include Head & Neck Cancer, Lung Cancer, Skin Cancer, Breast Cancer, Bone Cancers, Ovarian Cancer etc.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 2nd Neuro Oncology and Neurosurgery Conference, April 24-25, 2017 Dubai, UAE; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; 11th Leukemia Conference, October 05-06, 2017, London, UK; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 9th Molecular Cancer Biomarkers Conference, August 24-25, 2017, Birmingham, UK; Hematology & Oncology Conference, June 29-July 01, 2017, Bangkok, Thailand; EMBL Conference: Cancer Genomics, Heidelberg, Nov 05-08, 2017 Germany; 30th Annual Meeting Danish Association for Cancer Research, April 28, 2017, Denmark; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Irish Association for Cancer Research Cancer Conference, February 22 – 24, 2017, Kilkenny, Ireland; 19th AEK  Cancer Congress, March 01- 03, 2017, Heidelberg, Germany

Cancer Metastasis

Metastasis is the spread of a cancer or other disease from one organ or part of the body to another without being directly connected with it. When cancer cells break away from a tumour, they can travel to other areas of the body through the bloodstream or the lymph system. The lungs, liver, brain, and bones are the most common metastasis locations from solid tumors. Treatment and survival is determined, to a great extent, by whether or not a cancer remains localized or spreads to other locations in the body.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology Case Reports Meeting, Aug 29-31, 2017, London, UK; 2nd Gynaecologic Oncology Congress, Aug 28-29, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; Frontiers in Cancer Immunotherapy Conference, Feb 27–28 2017, New York City, USA; European Cancer Congress, Jan 27-30, 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; 6th Breast Cancer Conference, Feb 17-19, 2017, Hong Kong, China; World Cancer Congress, October 01 – 04, 2018 Kuala Lumpur, Malaysia; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain

Cancer Genetics

Cancer is a genetic disease—that is, cancer is caused by certain changes to genes that control the way our cells function, especially how they grow and divide.Genetic changes that increase cancer risk can be inherited from our parents if the changes are present in germ cells.Cancer-causing genetic changes can also be acquired during one’s lifetime, as the result of errors that occur as cells divide during a person’s lifetime or exposure to substances, such as certain chemicals in tobacco smoke, and radiation, such as ultraviolet rays from the sun, that damage DNA.Cancers that are not caused by inherited genetic mutations can sometimes appear to “run in families.”

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 2nd Neuro Oncology and Neurosurgery Conference, April 24-25, 2017 Dubai, UAE; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology & Cancer Summit, May 25-27, 2017, Osaka, Japan; 20th Radiation Oncology Conference, August 28-29, 2017, Brussels, Belgium; Immuno World 2017,  Jan 18-20 Jan 2017, Miami, US;  World Cancer Leaders' Summit, November 13-15, 2017, Mexico City, Mexico; 30th Annual Meeting Danish Association for Cancer Research, 28 April 2017, Denmark; 19th AEK Cancer Congress, March 01- 03 2017, Heidelberg, Germany; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK

Cancer & Tumour Immunology

Cancer immunology studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted and tumour marker-based diagnostic tests. Understanding these interactions is important for the development of new therapies for cancer treatment. Also, certain cancers are caused due to viruses as well.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 10th Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; 2nd Medical Imaging and Clinical Research Congress, Sep 11-12, 2017 Paris, France; World Immunology Congress, Dec 14-15, 2017 Dubai, UAE; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Frontiers in Cancer Immunotherapy, Feb 27–28 2017, New York City, USA; Global Conference on Cancer Therapy, Aug 07-09  2017, Frankfurt, Germany; Immuno-Oncology 360°,  Feb 01–03, 2017, New York, US; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Immuno World 2017, Jan 18-20 Jan 2017, Miami, US

Cancer: Genomics & Metabolomics

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell proliferation and the evolution of the cancer genome under mutation and selection by the body environment, the immune system and therapeutic interventions. The metabolites within a cell or biological system are being used to analyze cancer metabolism on a system-wide scale, painting a broad picture of the altered pathways and their interactions with each other. Cancer metabolomics involves chemical analysis by a range of analytical platforms through targeted/untargeted approaches. The application of metabolomics towards cancer research has led to a renewed appreciation of metabolism in cancer development and progression.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 2nd Neuro Oncology and Neurosurgery Conference, April 24-25, 2017 Dubai, UAE; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; 11th Leukemia Conference, October 05-06, 2017, London, UK; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 9th Molecular Cancer Biomarkers Conference, August 24-25, 2017, Birmingham, UK; Hematology & Oncology Conference, June 29-July 01, 2017, Bangkok, Thailand; EMBL Conference: Cancer Genomics, Heidelberg, Nov 05-08, 2017 Germany; 30th Annual Meeting Danish Association for Cancer Research, April 28, 2017, Denmark; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Irish Association for Cancer Research Cancer Conference, February 22 – 24, 2017, Kilkenny, Ireland; 19th AEK  Cancer Congress, March 01- 03, 2017, Heidelberg, Germany

Targeted Cancer Therapy

Targeted therapy is a newer type of cancer treatment that uses drugs or other substances to more precisely identify and attack cancer cells, usually while doing little damage to normal cells. Targeted therapy is a growing part of many cancer treatment regimens. Targeted therapy or molecularly targeted therapy is one of the major modalities of medical treatment (pharmacotherapy) for cancer. The Drugs work by targeting specific genes or proteins. These genes and proteins are found in cancer cells or in cells related to cancer growth, like blood vessel cells. As a form of molecular medicine, targeted therapy blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumour growth, rather than by simply interfering with all rapidly dividing cells.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology & Cancer Summit, May 25-27, 2017, Osaka, Japan; 20th Radiation Oncology Conference, August 28-29, 2017, Brussels, Belgium; Immuno World 2017,  Jan 18-20 Jan 2017, Miami, US;  World Cancer Leaders' Summit, November 13-15, 2017, Mexico City, Mexico; 30th Annual Meeting Danish Association for Cancer Research, 28 April 2017, Denmark; 19th AEK Cancer Congress, March 01- 03 2017, Heidelberg, Germany; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK

Stem Cell Therapy

Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is use to prevent the disease .The most common stem cells therapy is bone marrow transplant. Stems cells transplant is used to treatment of cancer like leukemia, multiple myeloma of lymphoma. Cord Blood Stem and Cancer  cord blood contains haematopoietic (blood) stem cell ,these cells make different types of cells like red blood cells white blood cells Haematopoietic stem cells, purified from bone marrow or blood, have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used .

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology Case Reports Meeting, Aug 29-31, 2017, London, UK; 2nd Gynaecologic Oncology Congress, Aug 28-29, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; Frontiers in Cancer Immunotherapy Conference, Feb 27–28 2017, New York City, USA; European Cancer Congress, Jan 27-30, 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; 6th Breast Cancer Conference, Feb 17-19, 2017, Hong Kong, China; World Cancer Congress, October 01 – 04, 2018 Kuala Lumpur, Malaysia; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain

Cancer Biomarkers

A cancer biomarker is an element or procedure that indicates the presence of cancer in the body. A biomarker may be any molecule released by presence a tumor or a specific indication of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 9th Molecular Cancer Biomarkers Conference, August 24-25, 2017, Birmingham, UK;Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Therapy and Treatments

Cancer can be treated by different processes like Radiation Therapy; Bone Marrow Transplantation this therapy takes place in case of leukaemia lymphoma and myeloma. Hormone Replacement Therapy  wherein the patient, in the course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones. Surgery and Laparoscopy describes the performance of surgical procedures with the assistance of a video camera and several thin instruments. Immunotherapy is a type of cancer treatment that helps immune system against fight cancer.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Alternative Medicine & Cancer 

Alternative medicine or complementary medicine are practices claimed to have the healing effects of medicine but are disproven, unproven, impossible to prove, or only harmful Alternative medicine consists of a wide variety of practices, products, and therapies—ranging from those that are biologically plausible but not well tested, to those with known harmful and toxic effects. An even greater proportion of cancer patients use “complementary” therapies along with mainstream cancer treatment.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Case Reports

A case report signifies the detailed report of symptoms, signs, diagnosis, treatment, and follow-up of an individual patient of a particular disease. Cancer Case reports have been playing a pivotal role in medical education, providing a structure for case-based learning and implementation throughout the world.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Novel Approaches to Cancer Therapeutics

The Normal treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added new modalities for cancer treatment.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Precision Medicine & Cancer Therapy

Precision medicine also known as Personalised Medicine is a phrase that is often used to describe how genetic information about a person’s disease is being used to diagnose or treat their disease. The deeper understanding of how cancer forms and grows has ushered in a new era of precision cancer care, where tailored treatments target abnormalities that may be found in each tumor’s DNA profile. This exciting innovation marks a shift, from traditional treatments designed for the average patient based on their success with a representative sample of people with similar cancers, toward more precise therapies.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Management & Prevention

Cancers that are closely linked to certain behaviours are the easiest to prevent. Many complementary health approaches are also there to combat the risks of cancers like—for example, herbal and other dietary supplements, acupuncture, massage, and yoga.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE;; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; 19th World Congress of Psycho-Oncology and Psychosocial Academy, 14 Aug 2017 - 18 Aug 2017, Berlin, Germany; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Pharmacology

Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Market Analysis Report

Summary

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity. Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues. There are more than 200 different types of cancer.

Importance & Scope

It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

Cancer Science 2017 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

For More details please visit: http://cancerscience.conferenceseries.com/

Why Lisbon?

Lisbon is the continental Europe's westernmost capital city. A leading Cancer Center in Portugal became the first in world to Edge™ Radiosurgery. Lisbon and its heavily populated surroundings are also developing as an important financial centre and a dynamic technological hub. It is also s recognised as a global city because of its importance in finance, commerce, media, entertainment, arts, international trade, education and tourism. Due to the advancements in the field of cancer research in Lisbon, it is been seen as the apt destination for the conference.

Brief Report of Market on Cancer Research

There are recent advancements in the cancer treatments & cancer care is accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018. This report   includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials.

Figure 1: Global Cancer Immunotherapies Market (2012-2018)

      

The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year

Annual global growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

The global market for biologic cancer treatment totalled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.

Figure 2: Global Market for Biologic Cancer Treatment(2014-2019)

         

Major Medical Universities 

Worldwide

  • Harvard University
  • University of Minnesota
  • Mayo Medical School
  • Pittsburgh School of Medicine
  • Yale University
  • University of Cambridge
  • University of Oxford Stanford University
  • Yale University
  • Emory University
  • John Hopkins University
  • Kings College London
  • Feinberg School of Medicine
  • University of Wisconsin
  • UNC School of Medicine
  • Karolinska University

In Europe

  • University of Sheffield
  • University of Manchester
  • University of Lisbon
  • King's College London
  • Newcastle University
  • University of Nottingham
  • University of Glasgow
  • University of Milan
  • University of Cambridge
  • University of Bristol
  • University of Aberdeen
  • Virginia Cancer Institute
  • University of Warwick
  • University of Oxford
  • University of Edinburgh
  • Sapienza Universita Di Roma
  • Durham University
  • Cardiff University

Major Associations

Worldwide

  • American Association for Cancer Research
  • Virginia Cancer Institute
  • American Brain Tumor Association
  • American Society of Pediatric Hematology/Oncology
  • Association of Cancer Physicians
  • American Childhood Cancer Organization
  • American Society of Clinical Oncology
  • Australasian Lung Cancer Trials Group
  • International Cancer Research Partnership (ICRP)
  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • International Agency for Research on Cancer (IARC)
  • Cancer Society of New Zealand
  • Irish Cancer Society
  • Australian Cervical Cancer Foundation
  • Medical Centre Cologne
  • Cancer Research UK
  • Australian Prostate Cancer Research
  • Peter McCollum Cancer Centre
  • The European Cancer Organization (ECCO)
  • German Cancer Research Centre

In Europe

  • Association of Cancer Physicians
  • British Gynaecological Cancer Society
  • Children with Cancer UK
  • United Kingdom Association of Cancer Registries
  • Prostate Cancer UK
  • UK Oncology Nursing Children’s Cancer and Leukaemia Group Society
  • Childhood Cancer Research Group Cancer Focus BASO
  • The Association for Cancer Surgery
  • Northern Ireland Cancer Research UK

Top Centres & Hospitals in Portugal

  • Portuguese Institute of Oncology Francisco Gentil of Coimbra,
  • Portugal Portuguese Institute of Oncology Francisco Gentil in Lisbon
  • Portugal Portuguese Institute of Oncology Francisco Gentil Port
  • Portugal Liga Portuguesa Contra o Cancro |
  • Portuguese Cancer League - Português
  • Europe Portugal - European Cancer Observatory
  • Hospital Lisbon Central
  • Santo Antonio General Hospital
  • Portuguese Institute of Oncology of Lisbon
  • Bonfim Central Clinic Ltd.
  • Hospital Center in the western Algarve
  • Jose de Mello Health Group
  • Braga Hospital
  • Hospital da Luz

Past Conference Report

World Cancer 2016

We extend a heartily thanks to all of our wonderful speakers, conference attendees as the World Cancer 2016 Conference was a great success!!

Conferenceseries LLC hosted the “12th World Cancer Conference” during September 26-28, 2016 at Hilton Heathrow Airport Hotel, London, UK. The conference was focused on Cancer & Oncology studies with the theme “Integrating every bit of cancer research: Prevention, diagnosis and cure”. Generous response and active participation was received from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2016 from Cancer & Oncology Conferences

The conference was initiated with Opening Ceremony followed by with a series of lectures delivered by both Honourable Guests and members of the Keynote forum.

The list included:

·         Alvaro Macieira-Coelho, French Institute of Health and Medical Research, France

·         Liane Deligdisch, Mount Sinai School of Medicine, USA

·         Katharina Pachmann, SIMFO GmbH Bayreuth, Germany

·         Ella L Kim, Johannes Gutenberg University Medical Centre, Germany

·         Qingyong Ma, Xi’an Jiaotong University, China

·         Sabine Mai, University of Manitoba, Canada

·         Nichola C Garbett, University of Louisville School of Medicine, USA

·         Alain Charest, Harvard Medical School, USA

We heartily acknowledge the conference moderator Dr. Jessie for her support for the conference. We are also gratified to various outside experts, company representatives and other renowned personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards World Cancer 2016

Trailing the success of World Cancer 2016, Conferenceseries LLC would like to announce the initiation of the “25th World Cancer Conference” to be held during October 19-21, 2017 at Rome, Italy

For More details: http://cancer.global-summit.com/europe/


Past Reports  Proceedings  Gallery  

Oncologists 2016

The success of the Oncologists  2016 conference has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “10th Global Annual Oncologists Meeting” during July 11-13, 2016 at Park Inn by Radisson Köln City West, Cologne, Germany

The conference was focused on learning about Oncologists with the theme “To Say There is Life after Cancer.The conference mainly directs towards addressing main issues like Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2016 is one of the most appreciated Cancer Conferences organized by Conferenceseries LLC. This Oncologists Meeting was discussed on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer,  blood cancer, cervical cancer, colon-rectum cancer, prostate cancer, thyroid cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Dr. Diana Anderson, University of Bradford, UK
  • Dr. Karl Reinhard Aigner, Medias Klinikum GmbH & Co KG, Germany
  • Dr. Hirendranath Banerjee, Elizabeth City State University, USA
  • Dr. Ajay Singh, Mitchell Cancer Institute, USA
  • Dr. Matin Burrow, DMB-Diagnostics GmbH, Germany
  • Dr. Martin Kristensson, Visiopharm, Denmark
  •  Dr.Michael Retsky, Harvard TH Chan School of Public Health, USA

Conferencesereies LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferencesereies LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Oncologists 2016, Conferencesereies LLC would like to announce the commencement of the “16th Global Annual Oncologists Meeting” to be held during April 24-25, 2017 Dubai, UAE. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology and cancer Research.


Past Reports  Proceedings  Gallery  

Cancer Diagnostics 2016

Conferenceseries LLC hosted the “Cancer Diagnostics Conference and Expo” during June 13-15, 2016 at Holiday Inn Aurelia Hotel, Rome, Italy,

The conference was focused on Cancer Diagnostics and research in developing new methods of diagnostic studies with the theme “Enhancing innovations in Cancer Diagnosis and treatment”. A series of invited lectures by Keynote Speakers and Honorable Guest on the scientific sessions which include: Cancer Diagnostics Market, Cancer Diagnostics Types, Cancer Screening Tests, Approaches in Cancer Therapy, Predictive Cancer Biomarkers, Cancer Genomics and Epigenetics, Cancer Treatment, Recent Diagnostics Technologies.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Diana Anderson, University of Bradford, United Kingdom.
  • Tibor Tot, Central Hospital Falun, Sweden.
  • Feng Yan, Nanjing Medical University Cancer Hospital and Jiangsu Cancer Hospital, China

Best Poster Awardees:

  • Majed Al Fayi, University of Liverpool, London, UK.
  • Julia Alejandra Pezuk, Hospital Sirio-Libanes, Brazil
  • Ramos L.C.B, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Brazil

OMICS International offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with OMICS International and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer Diagnostics 2016, OMICS International would like to announce the commencement of the “2nd Cancer Diagnostics Conference and Expo” to be held during May 08-10, 2017 Barcelona, Spain. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Research.

For More details: http://cancerdiagnostics.conferenceseries.com/

Let us meet again @ Cancer Diagnostics 2017


Past Reports  Gallery  

Cancer Therapy 2015

Thanks to all our admirable speakers, conference attendees contributed to the success of 5th World Congress on Cancer Therapy organized by OMICS International during September 28-30, 2015 Atlanta, Georgia, USA with the theme Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers which was a great success where eminent keynote speakers from various reputed universities, institutions and hospitals with their splendid presence addressed the gathering.

OMICS International would like to convey a warm gratitude to all Honorable Guests and Keynote Speakers of Cancer Therapy-2015:

Jack C. Westman, University of Wisconsin School of Medicine, USA
Erwin G. Van Meir, Winship Cancer Institute, USA
Yoshiaki Omura, New York Medical College, USA
Michael Weber, Weber Medical, Germany
Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

A review of cancer immunotherapies and nutritional therapies: Jack C. Westman, University of Wisconsin School of Medicine & Public Health, USA BAI1 is a brain-specific tumor suppressor: Erwin G. Van Meir, Winship Cancer Institute, Emory University, USA

New simple method of detecting various cancers & their biochemical information from rapidly changing part of QRS complex of ECGs and its clinical application for screening and evaluation of cancer: Yoshiaki Omura, New York Medical College, USA

Systemic and interstitial photodynamic laser therapy: New options in oncology: Michael Weber, Weber Medical, Germany

Chemoprevention of experimental mammary carcinoma by Trianthe ma portulacastrum Linn., an Indian dietary and medicinal plant: Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA

Cancer Therapy 2015 Organizing Committee would like to thank the Moderator of the conference, Sherri Z. Millis from Advanced Individual Medicine, LLC USA who contributed a lot to the smooth functioning of this event.

OMICS International, on behalf of the Cancer Therapy 2015, congratulates the best poster awardee, Sitelbanat Yassin, China Pharmaceutical University, Chinafor her outstanding performance and appreciates all the participants who put their research at poster presentations and sincerely wish them every success in their future endeavors. Also, we would like to thank the poster evaluation committee member Amy McCullough from American Humane Association, USA for his valuable support and advice.

OMICS International is honored to felicitate Cancer Therapy 2015 Organizing Committee and Editorial Board Members of Journal of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Chemotherapy, Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer Therapy 2015, OMICS International is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, 14th World Congress on Cancer Therapy to be held during June 5th - 7th, 2016 at Philadelphia, USA.


Past Reports  Proceedings  Gallery  

Cancer Middle East 2015

OMICS International’s 7th Global Summit on Cancer Therapy at Dubai, UAE October 05-07, 2015 was organized with a focus on Critical Review on “Rising helpful advances in cancer sorts” was a great success where eminent keynote speakers from various reputed institutions made their resplendent presence and addressed the gathering.

Cancer Middle East-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of Cancer research.

Cancer Middle East-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Terence B Culas, Government Medical College Palakkad, India, who contributed a lot for the smooth functioning of this event.

OMICS International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Cancer Middle East-2015.

Keynote Speakers of Cancer Middle East-2015:

Fritz Lahrtz, Isenbruck Bösl Hörschler LLP Prinzregentenstr, Germany

Ioannis Papasotiriou, RGCC International GmbH, Switzerland

Yunus A Luqmani, Kuwait University, Kuwait

Sadir J Alrawi, Tawam Hospital, UAE

OMICS International, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Deepak Kaul, Post Graduate Institute of Medical Education and Research, India for his valuable time.

Best Poster Winners:

Mariam Ahmed Fouad, Cairo University, Egypt

Nooshin Nourbakhsh, Isfahan University of Medical Sciences, Iran

OMICS International also took the privilege of felicitating Cancer Middle East-2015 Organizing Committee, Editorial Board Members of Journal of Cancer Science & TherapyJournal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Middle East-2015, OMICS International Conferences is glad to announce


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date July 17-19, 2017

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Journal of Integrative Oncology Journal of Carcinogenesis & Mutagenesis

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

exhibitor

Exhibitor

What People Say....

It was a very nice experience for me to share our findings with both young and well renowned scientist from different countries. The participation of the attendees and the feedback given to the speakers was sounding. Congratulations for the success of the conference.

Speaker

Javier Camacho, CINVESTAV, Mexico

I had a great time and enjoyed acting as a moderator in London conference. The conference was very good. Thank you for the kind arrangement.

Speaker

Jessie Qiaoyi Liang, The Chinese University of Hong Kong, China

Congratulations for your successful conference! I am very happy as a participant of your conference.

Speaker

Bo Yuan, Tokyo University of Pharmacy and Life Sciences, Japan

We had a very good time in London and we are looking forward to our next collaboration. The conference was well organized and the presentations of a high quality, with many interesting topics. Thank you very much for everything.

Speaker

Oana Stefana Purcaru, University of Medicine and Pharmacy of Craiova, Romania

Thank you for your invitation me as a keynote speaker on 12th World Cancer Conference held at Hilton London Heathrow Airport, London. I really enjoy the meeting.

Speaker

Qingyong Ma, Xian Jiaotong University, China

The conference was an enjoyable & memorable opportunity to meet with colleagues from all over the world, keep abreast of new thoughts & research into possibilities of investigation & treatment of cancer, and maintain updated information about current lines of management of cancer. The organization & administration of the conference was very good and the outcome will certainly have an impact on my thoughts and approach to management of cancer.

Speaker

Mohamed Emad El-Sayed, General Medical Council, UK